SGK phosphorylates Cdc25 and Myt1 to trigger cyclin B-Cdk1 activation at the meiotic G2/M transition

被引:29
|
作者
Hiraoka, Daisaku [1 ]
Hosoda, Enako [2 ]
Chiba, Kazuyoshi [2 ]
Kishimoto, Takeo [1 ]
机构
[1] Ochanomizu Univ, Sci & Educ Ctr, Tokyo, Japan
[2] Ochanomizu Univ, Dept Biol Sci, Tokyo, Japan
来源
JOURNAL OF CELL BIOLOGY | 2019年 / 218卷 / 11期
基金
日本学术振兴会;
关键词
MATURATION-PROMOTING FACTOR; BETA-GAMMA-SUBUNIT; OOCYTE MATURATION; CELL-CYCLE; SIGNALING PATHWAY; PLK1; ACTIVATION; PROTEIN-KINASE; MOTIF PHOSPHORYLATION; XENOPUS OOCYTE; MITOTIC ENTRY;
D O I
10.1083/jcb.201812122
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The kinase cyclin B-Cdk1 complex is a master regulator of M-phase in both mitosis and meiosis. At the G2/M transition, cyclin B-Cdk1 activation is initiated by a trigger that reverses the balance of activities between Cdc25 and Wee1/Myt1 and is further accelerated by autoregulatory loops. In somatic cell mitosis, this trigger was recently proposed to be the cyclin A-Cdk1/Plk1 axis. However, in the oocyte meiotic G2/M transition, in which hormonal stimuli induce cyclin B-Cdk1 activation, cyclin A-Cdk1 is nonessential and hence the trigger remains elusive. Here, we show that SGK directly phosphorylates Cdc25 and Myt1 to trigger cyclin B-Cdk1 activation in starfish oocytes. Upon hormonal stimulation of the meiotic G2/M transition, SGK is activated by cooperation between the G beta gamma-PI3K pathway and an unidentified pathway downstream of G beta gamma, called the atypical G beta gamma pathway. These findings identify the trigger in oocyte meiosis and provide insights into the role and activation of SGK.
引用
收藏
页码:3597 / 3611
页数:15
相关论文
共 50 条
  • [21] CenpH regulates meiotic G2/M transition by modulating the APC/CCdh1-cyclin B1 pathway in oocytes
    Zhang, Teng
    Zhou, Yang
    Li, Li
    Wang, Zhen-Bo
    Shen, Wei
    Schatten, Heide
    Sun, Qing-Yuan
    DEVELOPMENT, 2017, 144 (02): : 305 - 312
  • [22] MYT1 BLOCKADE AS A NOVEL GLIOMA THERAPEUTICS THROUGH ABROGATIING OF THE G2/M CELL CYCLE CHECKPOINT
    Lang, Fengchao
    Cornwell, James
    Zhang, Wei
    Zhang, Meili
    Song, Hua
    Aladjem, Mirit
    Aregger, Michael
    Cappell, Steven
    Yang, Chunzhang
    NEURO-ONCOLOGY, 2024, 26
  • [23] Activation of Both Mos and Cdc25 Is Required for G2-M Transition in Perch Oocyte
    Priyadarshini, Anamika
    Basu, Dipanjan
    Navneet, A. K.
    Bhattacharya, Anirban
    Bhattacharya, Shelley
    Maitra, Sudipta
    Bhattacharya, Samir
    MOLECULAR REPRODUCTION AND DEVELOPMENT, 2009, 76 (03) : 289 - 300
  • [24] KCTD12 promotes tumorigenesis by facilitating CDC25B/CDK1/Aurora A-dependent G2/M transition
    Zhong, Y.
    Yang, J.
    Xu, W. W.
    Wang, Y.
    Zheng, C-C
    Li, B.
    He, Q-Y
    ONCOGENE, 2017, 36 (44) : 6177 - 6189
  • [25] KCTD12 promotes tumorigenesis by facilitating CDC25B/CDK1/Aurora A-dependent G2/M transition
    Y Zhong
    J Yang
    W W Xu
    Y Wang
    C-C Zheng
    B Li
    Q-Y He
    Oncogene, 2017, 36 : 6177 - 6189
  • [26] Human Cdc14B Promotes Progression through Mitosis by Dephosphorylating Cdc25 and Regulating Cdk1/Cyclin B Activity
    Tumurbaatar, Indra
    Cizmecioglu, Onur
    Hoffmann, Ingrid
    Grummt, Ingrid
    Voit, Renate
    PLOS ONE, 2011, 6 (02):
  • [27] The G2 DNA damage checkpoint targets both Wee1 and Cdc25
    Raleigh, JM
    O'Connell, MJ
    JOURNAL OF CELL SCIENCE, 2000, 113 (10) : 1727 - 1736
  • [28] DRG2 regulates G2/M progression via the cyclin B1-Cdk1 complex
    Jang, S.
    Thao, D. Thi
    Kim, S.
    Park, J.
    Han, I.
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26
  • [29] DRG2 Regulates G2/M Progression via the Cyclin B1-Cdk1 Complex
    Jang, Soo Hwa
    Kim, Ah-Ram
    Park, Neung-Hwa
    Park, Jeong Woo
    Han, In-Seob
    MOLECULES AND CELLS, 2016, 39 (09) : 699 - 704
  • [30] Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas
    Butz, Henriett
    Nemeth, Kinga
    Czenke, Dora
    Liko, Istvan
    Czirjak, Sandor
    Zivkovic, Vladimir
    Baghy, Kornelia
    Korbonits, Marta
    Kovalszky, Ilona
    Igaz, Peter
    Racz, Karoly
    Patocs, Attila
    PATHOLOGY & ONCOLOGY RESEARCH, 2017, 23 (03) : 633 - 641